PL02.01 Overall Survival with Durvalumab Versus Placebo...

Journal of Thoracic Oncology 2018 / 10 Vol. 13; Iss. 10

PL02.01 Overall Survival with Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC

Antonia, S., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K.H., De Wit, M., Cho, B.C., Bourhaba, M., Quantin, X., Tokito, T., Mekhail, T., Planchard, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.010
Date:
October, 2018
File:
PDF, 171 KB
english, 2018
Conversion to is in progress
Conversion to is failed